iShares iBonds Dec 2032 Term Corporate ETF (IBDX) profile & fees
Per-holding contribution · concentration · sector skew — a deep read
Fund overview
This is a US-listed ETF from BlackRock. It tracks the Bloomberg December 2032 Maturity Corporate Index. Key facts — expense ratio 0.1%; net assets about $1.8B; inception Jun 28, 2022. Its 1-year return is -1.51%.
Fund details
Fund overview
This is a US-listed ETF from BlackRock. It tracks the Bloomberg December 2032 Maturity Corporate Index. Key facts — expense ratio 0.1%; net assets about $1.8B; inception Jun 28, 2022. Its 1-year return is -1.51%.
0 identified stocks · net exposure / NAV 0.00%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.
Weight and calculation basis
0 identified stocks · net exposure / NAV 0.00%. Display weights are normalized to 100%; calculations retain original exposures without an additional leverage multiplier. Cash and unallocated contracts are excluded from stock attribution.
Holdings for this ETF haven't been collected yet. The auto-harvester will fill this page in shortly — meanwhile, explore other ETFs below.
IBDX comments
Leave a one-line take on iShares iBonds Dec 2032 Term Corporate ETF. No account — just a nickname and a code to delete it later.
Loading…
Similar ETFs
Picked by how much their actual holdings overlap. The higher the overlap, the less diversification you get from owning both.